ABBV
AbbVie$161.67
ABBV info-0.38%ย โ€ข 24 H
Dividend Yield:3.5%
Global Rank#34
Market Cap$286.32B
YTD Performance4.37%
P/E24.38
Revenue$58.05B
Change 7d-4.10%
SP500 BenchmarkUnderperform
P/S4.93
Earnings$11.85B

AbbVie (ABBV) Stock Overview

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behรงet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; Genentech, Inc.; California Institute for Biomedical Research (Calibr), and BigHat Biosciences, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

ABBV Stock Information

SymbolABBV
Address
1 North Waukegan RoadNorth Chicago, IL 60064-6400United States
Founded-
Trading hours9:30 AM - 4:00 PM ET
Websitehttps://www.abbvie.com
Country๐Ÿ‡บ๐Ÿ‡ธ United States
Phone Number847 932 7900

AbbVie (ABBV) Price Chart

-
Value:-

AbbVie Overview: Key Details and Summary

Stock data
2022
Change
Price
$161.67
N/A
Market Cap
$286.32B
N/A
Shares Outstanding
1.77B
0.06%
Employees
50.00K
N/A
Shareholder Equity
17.29B
11.99%
Valuation
2022
Change
P/E Ratio
24.38
N/A
P/S Ratio
4.93
N/A
P/B Ratio
16.56
N/A
P/FCF
11.81
N/A
POE
0.00
N/A
Dividends
2022
Change
Dividend Yield
3.51%
N/A
Dividend per share
5.6708
N/A
Dividend Payout Ratio
0.8479
N/A
Growth
2022
Change
ROIC
0.1636
N/A
WACC
0.0210
N/A
CAPEX
-695.00M
N/A
Return on Equity
0.6852
N/A
Earnings
2022
Change
Revenue
$58.05B
N/A
Earnings
$11.85B
N/A
Free Cash Flow
$24.25B
N/A
EPS
6.63
N/A
Earnings Yield
0.041
N/A
Gross Margin
0.7
N/A
Operating Margin
0.3241
N/A
Net income margin
0.204
N/A
FCF Margin
0.4177
N/A
Financial Strength
2022
Change
Total Assets
$138.81B
N/A
Total Debt
$63.27B
N/A
Cash on Hand
$9.23B
N/A
Debt to Equity
$7.03
-17.23%
Cash to Debt
0.1459
13.79%
POE
0.0000
N/A
Current Ratio
0.9636
21.43%
Other data
2022
Change
Buyback Yield
0.0052
N/A
ยฉ 2024 TopStocks.org
Facebook Icon
Twitter Icon
Linkedin Icon